Atlas Trials

The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic Cancer

Clinical trial NCT01487902 · UNKNOWN

Trial details

NCT number
NCT01487902
Sponsor
Asan Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Castration-resistant Prostate Cancer
Start date
2010-07-01
Primary completion
2013-10-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.